About

Company Overview

About

Axis Therapeutics is a leading cancer immunotherapy company focused on the development of T cell therapies.

The Company is developing a novel class of innovative TCR-T therapies designed to harness the immune system to recognize and destroy cancerous cells in more patients, more effectively.

Through the TCR-T technology platform, the Company has generated engineered T cells with higher binding affinity and specificity for a defined tumor antigen.  Preliminary studies have shown positive clinical signals in subjects with multiple solid tumor types.

We believe our TCR-T platform will be able to target a broad range of solid tumors, and provide patients with potentially long term effective cancer control without the need for sustained supportive care.

Get in touch with us

Science

News

Contact

logo-white.png

About

© Copyright Axis Therapeutics 2020. All Rights Reserved.